<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7293728\results\search\drug\results.xml">
  <result pre="vitro). Oseltamivir was obtained from Roche Co., Ltd. (Basel, Switzerland)." exact="Ribavirin" post="was purchased from Star Lake Bioscience Co., Ltd. (Zhaoqing"/>
  <result pre="tosyl-phenylalanine chloromethyl-ketone (TPCK) treated trypsin (Sigma), 100â€‰U/ml penicillin, and 100â€‰Î¼g/ml" exact="streptomycin" post="(Gibco). The plate was incubated at 34Â°C, 5% CO2,"/>
  <result pre="infected mice, 60 mice were divided into 6 groups (placebo," exact="ribavirin" post="75â€‰mg/kg/day, LQ 100/200/400â€‰mg/kg/day, uninfected control, nâ€‰=â€‰10): 5 groups (placebo,"/>
  <result pre="ribavirin 75â€‰mg/kg/day, LQ 100/200/400â€‰mg/kg/day, uninfected control, nâ€‰=â€‰10): 5 groups (placebo," exact="ribavirin" post="75â€‰mg/kg/day, LQ 100/200/400â€‰mg/kg/day) were inoculated with 5-fold 50% lethal"/>
  <result pre="days after IBV infection (Figure 5(b)). In the positive control," exact="ribavirin" post="treated mice (Figure 5(c)), there were a few inflammatory"/>
  <result pre="(average valueâ€‰=â€‰log 4.5 TCID50/g). Interestingly, viral load of 75â€‰mg/kg/day of" exact="ribavirin" post="treated mice (average valueâ€‰=â€‰log 3.17 TCID50/g) was lower than"/>
  <result pre="10â€‰mg/kg/day of oseltamivir treated mice (Figure 7(h)) and 75â€‰mg/kg/day of" exact="ribavirin" post="treated mice (Figure 7(b)), and mild pneumonia was observed"/>
  <result pre="many studies evaluating combinations of agents, including amantadine, oseltamivir, and" exact="ribavirin" post="[28â€&quot;30] antiviral therapy with anti-inflammatory drugs or antioxidant [31â€&quot;33],"/>
  <result pre="severe influenzaThe Lancet Infectious Diseases201414121259127010.1016/s1473-3099(14)70821-725213733 28BeigelJ. H.BaoY.BeelerJ.et al.Oseltamivir, amantadine, and" exact="ribavirin" post="combination antiviral therapy versus oseltamivir monotherapy for the treatment"/>
  <result pre="F.BarnardD. L.et al.Efficacy of combined therapy with amantadine, oseltamivir, and" exact="ribavirin" post="in vivo against susceptible and amantadine-resistant influenza A virusesPLoS"/>
  <result pre="A virusesPLoS One20127110.1371/journal.pone.0031006 30SmeeD. F.WongM.-H.BaileyK. W.SidwellR. W.Activities of oseltamivir and" exact="ribavirin" post="used alone and in combination against infections in mice"/>
  <result pre="mice without prior adaptation and responds to a combination of" exact="zanamivir" post="and COX-2 inhibitorPLoS One20149910.1371/journal.pone.0107966 32OttoliniM.BlancoJ.PorterD.PetersonL.CurtisS.PrinceG.Combination anti-inflammatory and antiviral therapy"/>
  <result pre="influenza in a cotton rat modelPediatric Pulmonology200336429029410.1002/ppul.1032012950040 33GhezziP.UngheriD.Synergistic combination of" exact="N-acetylcysteine" post="and ribavirin to protect from lethal influenza viral infection"/>
  <result pre="a cotton rat modelPediatric Pulmonology200336429029410.1002/ppul.1032012950040 33GhezziP.UngheriD.Synergistic combination of N-acetylcysteine and" exact="ribavirin" post="to protect from lethal influenza viral infection in a"/>
  <result pre="Medicine2010361334110.1007/s00134-009-1727-619924393 35ZhangA. J. X.LiC.ToK. K. W.et al.Toll-like receptor 7 agonist" exact="imiquimod" post="in combination with influenza vaccine expedites and augments humoral"/>
 </snippets>
</snippetsTree>
